Get started
Author

Алексей Дегтярев

Observed names: A. M. Degtiarev, A. M. Degtyarev, Алексей Михайлович Дегтярев, Дегтярев Алексей Михайлович
Observed institution: Oncological Dispensary No. 2
ORCID: 0000-0002-4206-223X
Observed ORCIDs: 0000-0002-4206-223X, 0009-0006-2271-9675
OpenAlex ID: A5109712989
Ten-Year Response to Crizotinib in ALK-positive Inflammatory Myofibroblastic Tumors: Case Reports
2024 · Арам Ашотович Мусаелян, Александр Сергеевич Устюжанинов, et al. · Voprosy Onkologii · 2
Morphological Characteristic and Clinical Value of Different Types of Tumor Vessels in Breast Cancer
2016 · N. V. Nikitenko, M. A. Senchukova, et al. · Russian Journal of Biotherapy · 2
PDF
Efficacy of atezolizumab in patients resistant to platinum-based chemotherapy. Results of the AURORA-RU Study: Atezolizumab in UROthelial cancer: Real-world Analysis of RUssia
2026 · Evgeniy A. Usynin, O. V. Leonov, et al. · Cancer Urology · 1
PDF
Capmatinib in patients with MET-positive advanced non-small cell lung cancer: analysis of the Russian cohort in the Geometry mono-1 study
2022 · Сергей Орлов, Арам Мусаелян, et al. · Voprosy Onkologii · 1
PDF
Predictive markers of response to immunotherapy in uterine cancer
2023 · Арам Мусаелян, Аглая Иевлева, et al. · Voprosy Onkologii
PDF
Works count: 8
Citation count: 6
H-index: 2
I10-index:
Year
Topic
Type